Molina Healthcare, Inc. (MOH) stock
MOHNYSEHospital & Medical Service PlansFiscal year ends December 31
$204.78+5.83 (+2.93%)
Close on Oct 30, 2026Market cap $10.69BP/E –Yield –
Earnings
Molina Healthcare's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 4, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$11.08B
adjusted income per diluted share, Q3 FY2026
$0.89
$1.84 a year earlier
Latest guidance
Issued
Oct 21, 2026 · 3 items
Quarterly results
Revenue and earnings per share from each of Molina Healthcare's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 4, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 21, 2026after the close | $11.08B | – | $0.73 | $0.89 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 22, 2026after the close | – | – | $1.19 | $1.51 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 22, 2026after the close | – | – | $0.27 | $2.35 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 5, 2026after the close | $11.38B | +8.3% | -$3.15 | -$2.75 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025after the close | – | – | $1.51 | $1.84 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025after the close | $11.43B | +15.7% | $4.75 | $5.48 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025after the close | $11.15B | +12.2% | $5.45 | $6.08 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 5, 2025after the close | $10.50B | +16.0% | $4.44 | $5.05 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024after the close | $10.34B | +21.0% | $5.65 | $6.01 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024after the close | $9.88B | +18.7% | $5.17 | $5.86 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024after the close | $9.93B | +21.9% | $5.17 | $5.73 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 7, 2024after the close | $9.05B | +10.0% | $3.70 | $4.38 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023after the close | $8.55B | +7.8% | $4.21 | $5.05 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023after the close | $8.33B | +3.4% | $5.35 | $5.65 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023after the close | $8.15B | +4.9% | $5.52 | $5.81 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 8, 2023after the close | $8.22B | +11.0% | $0.96 | $4.10 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022after the close | $7.93B | +12.6% | $3.95 | $4.36 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022after the close | $8.05B | – | $4.25 | $4.55 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022after the close | $7.77B | – | $4.39 | $4.90 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 9, 2022after the close | $7.41B | – | $1.74 | $2.88 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021after the close | $7.04B | – | $2.46 | $2.83 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 10, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 28, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Molina Healthcare's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Premium revenue | FY2026 | $42.00B | – | New | Oct 21, 2026 |
| Premium revenue | FY2026 | $42.00B | $42.00B | Reaffirmed | Jul 22, 2026 |
| Adjusted Pre-tax Marginnon-GAAP | FY2026 | 0.8% | – | New | Feb 5, 2026 |
| GAAP Pre-tax MarginGAAP | FY2026 | 0.5% | – | New | Feb 5, 2026 |
| GAAP earningsGAAP | FY2026 | $2.38 | – | New | Oct 21, 2026 |
| GAAP earningsGAAP | FY2026 | $2.15 | $1.90 | Raised | Jul 22, 2026 |
| adjusted earningsnon-GAAP | FY2026 | $5.25 | – | New | Oct 21, 2026 |
| adjusted earningsnon-GAAP | FY2026 | $5.25 | $5.00 | Raised | Jul 22, 2026 |
| Adjusted G&A Rationon-GAAP | FY2026 | 6.4% | – | New | Feb 5, 2026 |
| Adjusted Net Incomenon-GAAP | FY2026 | $256.00M | – | New | Feb 5, 2026 |
| Diluted weighted average shares | FY2026 | 51.1 | – | New | Feb 5, 2026 |
| Effective Tax Rate | FY2026 | 30% | – | Lowered | Feb 5, 2026 |
| GAAP G&A RatioGAAP | FY2026 | 6.5% | – | New | Feb 5, 2026 |
| GAAP Net IncomeGAAP | FY2026 | $164.00M | – | New | Feb 5, 2026 |
| MCR | FY2026 | 92.6% | – | New | Feb 5, 2026 |
| Year End Total Membership | FY2026 | 5.1 | – | Lowered | Feb 5, 2026 |
Guidance vs results
The last range Molina Healthcare gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2025 | implied fourth quarter 2025 adjusted earnings | $0.35 | -$2.75 | Below range |
Guidance history
Every forecast Molina Healthcare put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 21, 2026 | adjusted earnings | FY2026 | $5.25 | New |
| Oct 21, 2026 | GAAP earnings | FY2026 | $2.38 | New |
| Oct 21, 2026 | Premium revenue | FY2026 | $42.00B | New |
| Jul 22, 2026 | adjusted earnings | FY2026 | $5.25 | Raised |
| Jul 22, 2026 | GAAP earnings | FY2026 | $2.15 | Raised |
| Jul 22, 2026 | Premium revenue | FY2026 | $42.00B | Reaffirmed |
| Apr 22, 2026 | adjusted earnings | FY2026 | $5.00 | Reaffirmed |
| Apr 22, 2026 | GAAP earnings | FY2026 | $1.90 | Lowered |
| Apr 22, 2026 | premium revenue | FY2026 | $42.00B | Lowered |
| Feb 5, 2026 | adjusted earnings per diluted share | FY2026 | $5.00 | New |
| Feb 5, 2026 | GAAP earnings per diluted share | FY2026 | $3.20 | New |
| Feb 5, 2026 | GAAP Pre-tax Margin | FY2026 | 0.5% | New |
| Feb 5, 2026 | Adjusted Pre-tax Margin | FY2026 | 0.8% | New |
| Feb 5, 2026 | MCR | FY2026 | 92.6% | New |
| Feb 5, 2026 | Diluted weighted average shares | FY2026 | 51.1 | New |
| Feb 5, 2026 | Year End Total Membership | FY2026 | 5.1 | Lowered |
| Feb 5, 2026 | Effective Tax Rate | FY2026 | 30% | Lowered |
| Feb 5, 2026 | GAAP G&A Ratio | FY2026 | 6.5% | New |
| Feb 5, 2026 | Adjusted G&A Ratio | FY2026 | 6.4% | New |
| Feb 5, 2026 | GAAP Net Income | FY2026 | $164.00M | New |
| Feb 5, 2026 | Adjusted Net Income | FY2026 | $256.00M | New |
| Feb 5, 2026 | premium revenue | FY2026 | $42.00B | New |
| Feb 5, 2026 | Total Revenue | FY2026 | $44.50B | Raised |
| Oct 22, 2025 | implied fourth quarter 2025 adjusted earnings | Q4 FY2025 | $0.35 | New |
| Oct 22, 2025 | Premium Revenue | FY2025 | $42.50B | New |
| Jul 23, 2025 | Adjusted EPS – Diluted | FY2025 | $19.00 | Lowered |
| Jul 23, 2025 | GAAP EPS – Diluted | FY2025 | $16.90 | Lowered |
| Jul 23, 2025 | Diluted weighted average shares | FY2025 | 54.1 | New |
| Jul 23, 2025 | MCR | FY2025 | 90.2% | Raised |
| Jul 23, 2025 | Medicaid | FY2025 | 90.9% | Raised |
| Jul 23, 2025 | Medicare | FY2025 | 90% | Lowered |
| Jul 23, 2025 | Marketplace | FY2025 | 85.1% | Lowered |
| Jul 23, 2025 | Effective Tax Rate | FY2025 | 25.3% | Lowered |
| Jul 23, 2025 | GAAP G&A Ratio | FY2025 | 6.7% | Raised |
| Jul 23, 2025 | GAAP Pre-tax Margin | FY2025 | 2.8% | Lowered |
| Jul 23, 2025 | Adjusted G&A Ratio | FY2025 | 6.6% | Raised |
| Jul 23, 2025 | Adjusted Pre-tax Margin | FY2025 | 3.1% | Lowered |
| Jul 23, 2025 | Premium Revenue | FY2025 | $42.00B | New |
| Jul 23, 2025 | GAAP Net Income | FY2025 | $912.00M | New |
| Jul 23, 2025 | Adjusted Net Income | FY2025 | $1.03B | New |
| Jul 23, 2025 | Total Revenue | FY2025 | $44.00B | New |
| Jul 7, 2025 | adjusted earnings per share | FY2025 | $21.50 – $22.50 | Lowered |
| Jul 7, 2025 | GAAP Net income per diluted share | FY2025 | $19.32 – $20.32 | Lowered |
| Apr 23, 2025 | full year adjusted earnings | FY2025 | $24.50 | Reaffirmed |
| Apr 23, 2025 | full year GAAP earnings | FY2025 | $22.32 | Lowered |
| Apr 23, 2025 | Premium revenue | FY2025 | $42.00B | Lowered |
| Feb 5, 2025 | adjusted earnings per share growth | FY2025 | +8% | New |
| Feb 5, 2025 | adjusted earnings per share | FY2025 | $24.50 | New |
| Feb 5, 2025 | GAAP earnings per share | FY2025 | $22.50 | New |
| Feb 5, 2025 | MCR | FY2025 | 88.7% | New |
| Feb 5, 2025 | Effective Tax Rate | FY2025 | 25.3% | Lowered |
| Feb 5, 2025 | GAAP G&A Ratio | FY2025 | 7.2% | New |
| Feb 5, 2025 | GAAP After-tax Margin | FY2025 | 2.8% | Lowered |
| Feb 5, 2025 | Adjusted G&A Ratio | FY2025 | 7% | New |
| Feb 5, 2025 | Adjusted After-tax Margin | FY2025 | 3.1% | Lowered |
| Feb 5, 2025 | Premium revenue increase | FY2025 | +9% | New |
| Feb 5, 2025 | Premium revenue | FY2025 | $42.00B | New |
| Feb 5, 2025 | Total Revenue | FY2025 | $44.00B | Raised |
| Oct 23, 2024 | Adjusted earnings per diluted share | FY2024 | $23.50 | Reaffirmed |
| Oct 23, 2024 | GAAP Net income Per Diluted Share | FY2024 | $21.59 | Lowered |
| Oct 23, 2024 | GAAP Net income | FY2024 | $1.25B | Lowered |
| Oct 23, 2024 | Adjusted net income | FY2024 | $1.36B | Lowered |
| Oct 23, 2024 | Premium revenue | FY2024 | $38.00B | Reaffirmed |
| Jul 24, 2024 | adjusted earnings per diluted share | FY2024 | $23.50 | Reaffirmed |
| Jul 24, 2024 | Premium revenue | FY2024 | $38.00B | Reaffirmed |
| Apr 24, 2024 | adjusted earnings per diluted share | FY2024 | $23.50 | Reaffirmed |
| Apr 24, 2024 | GAAP Net income | FY2024 | $21.79 | Lowered |
| Apr 24, 2024 | Premium revenue | FY2024 | $38.00B | Lowered |
| Feb 7, 2024 | Adjusted EPS – Diluted | FY2024 | $23.50 | New |
| Feb 7, 2024 | GAAP EPS – Diluted | FY2024 | $22.00 | New |
| Feb 7, 2024 | Diluted weighted average shares | FY2024 | 58.1 | New |
| Feb 7, 2024 | Year End Total Membership | FY2024 | 5.7 | Lowered |
| Feb 7, 2024 | Medicaid | FY2024 | 5.1 | Lowered |
| Feb 7, 2024 | Medicare | FY2024 | 270 | Raised |
| Feb 7, 2024 | Marketplace | FY2024 | 370 | Raised |
| Feb 7, 2024 | MCR | FY2024 | 88.2% | New |
| Feb 7, 2024 | Effective Tax Rate | FY2024 | 25.7% | Lowered |
| Feb 7, 2024 | GAAP G&A Ratio | FY2024 | 7.1% | New |
| Feb 7, 2024 | GAAP After-tax Margin | FY2024 | 3.2% | Lowered |
| Feb 7, 2024 | Adjusted G&A Ratio | FY2024 | 7% | New |
| Feb 7, 2024 | Adjusted After-tax Margin | FY2024 | 3.4% | Lowered |
| Feb 7, 2024 | Premium Revenue | FY2024 | $38.00B | New |
| Feb 7, 2024 | GAAP Net Income | FY2024 | $1.28B | New |
| Feb 7, 2024 | Adjusted Net Income | FY2024 | $1.37B | New |
| Feb 7, 2024 | Total Revenue | FY2024 | $39.60B | New |
| Oct 25, 2023 | adjusted earnings per share | FY2023 | $20.75 | Reaffirmed |
| Jul 26, 2023 | adjusted earnings per share guidance | FY2023 | $20.75 | Raised |
| Apr 26, 2023 | adjusted earnings per share | FY2023 | $20.25 | Raised |
| Feb 8, 2023 | Adjusted EPS – Diluted | FY2023 | $19.75 | New |
| Feb 8, 2023 | GAAP EPS – Diluted | FY2023 | $18.53 | New |
| Feb 8, 2023 | Diluted weighted average shares | FY2023 | 58.1 | New |
| Feb 8, 2023 | Year End Total Membership | FY2023 | 5.1 | Lowered |
| Feb 8, 2023 | Medicaid | FY2023 | 4.7 | Lowered |
| Feb 8, 2023 | Medicare | FY2023 | 175 | Raised |
| Feb 8, 2023 | Marketplace | FY2023 | 230 | Raised |
| Feb 8, 2023 | MCR | FY2023 | 88% | New |
| Feb 8, 2023 | Effective Tax Rate | FY2023 | 25.3% | Lowered |
| Feb 8, 2023 | GAAP G&A Ratio | FY2023 | 7% | New |
| Feb 8, 2023 | GAAP After-tax Margin | FY2023 | 3.3% | Lowered |
| Feb 8, 2023 | Adjusted G&A Ratio | FY2023 | 7% | New |
| Feb 8, 2023 | Adjusted After-tax Margin | FY2023 | 3.5% | Lowered |
| Feb 8, 2023 | Premium Revenue | FY2023 | $32.00B | New |
| Feb 8, 2023 | GAAP Net Income | FY2023 | $1.08B | New |
| Feb 8, 2023 | Adjusted Net Income | FY2023 | $1.15B | New |
| Feb 8, 2023 | Total Revenue | FY2023 | $33.00B | New |
| Oct 26, 2022 | adjusted earnings | FY2022 | $17.75 | Raised |
| Oct 26, 2022 | premium revenue | FY2022 | $30.50B | Raised |
| Jul 27, 2022 | adjusted earnings | FY2022 | $17.60 | Raised |
| Jul 27, 2022 | Premium revenue | FY2022 | $30.00B | Raised |
| Apr 27, 2022 | adjusted earnings | FY2022 | $17.10 | Raised |
| Apr 27, 2022 | Premium revenue | FY2022 | $29.25B | Lowered |
| Feb 9, 2022 | adjusted earnings per share | FY2022 | $17.00 | New |
| Feb 9, 2022 | GAAP EPS – Diluted | FY2022 | $15.73 | New |
| Feb 9, 2022 | Diluted weighted average shares | FY2022 | 58.4 | New |
| Feb 9, 2022 | Year End Total Membership | FY2022 | 4.5 | Lowered |
| Feb 9, 2022 | Medicaid | FY2022 | 4.1 | Lowered |
| Feb 9, 2022 | Medicare | FY2022 | 150 | Raised |
| Feb 9, 2022 | Marketplace | FY2022 | 250 | Raised |
| Feb 9, 2022 | MCR | FY2022 | 88% | New |
| Feb 9, 2022 | Effective Tax Rate | FY2022 | 25.4% | Lowered |
| Feb 9, 2022 | GAAP G&A Ratio | FY2022 | 6.9% | New |
| Feb 9, 2022 | GAAP After-tax Margin | FY2022 | 3.1% | Lowered |
| Feb 9, 2022 | Adjusted G&A Ratio | FY2022 | 6.8% | New |
| Feb 9, 2022 | Adjusted After-tax Margin | FY2022 | 3.4% | Lowered |
| Feb 9, 2022 | Premium revenue | FY2022 | $28.50B | New |
| Feb 9, 2022 | GAAP Net Income | FY2022 | $919.00M | New |
| Feb 9, 2022 | Adjusted Net Income | FY2022 | $993.00M | New |
| Feb 9, 2022 | total revenue | FY2022 | $29.50B | New |
| Oct 27, 2021 | adjusted earnings per share | FY2021 | $13.25 | New |
| Oct 27, 2021 | Net income per diluted share | FY2021 | $11.61 | New |
| Oct 27, 2021 | Premium revenue | FY2021 | $26.50B | New |
| Oct 27, 2021 | total revenue | FY2021 | $27.50B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Molina Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
- News
- Update
- Update
- Update
- Results
- Results
- Results
- Results
- Update